Chicago Rivet & Machine (CVR) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Sales for Q2 2026 were $7.24M, down 0.8% year-over-year; six-month sales were $14.09M, down 3.1% year-over-year, mainly due to lower fastener segment demand and macroeconomic headwinds.
Net loss for Q2 2026 was $989.5K ($1.02/share), up from a $395K loss in Q2 2025; six-month net loss was $1.35M versus net income of $6K in the prior year period.
Gross margin declined 42.2% year-over-year for both the quarter and six months, driven by lower volumes, unfavorable mix, and higher costs.
Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses, negative cash flows, and reduced liquidity.
Financial highlights
Q2 2026 net sales: $7.24M (Q2 2025: $7.30M); six months: $14.09M (2025: $14.54M).
Q2 2026 gross profit: $563K (Q2 2025: $975K); six months: $1.52M (2025: $2.63M).
Q2 2026 net loss: $990K (Q2 2025: $395K); six months: $1.35M loss (2025: $6K income).
Cash and equivalents at June 30, 2026: $771K; working capital: $8.70M, down 12.1% from year-end.
Operating cash flow for six months: $(1.76)M; capital expenditures: $189K.
Outlook and guidance
Fiscal 2026 guidance remains cautious amid macroeconomic uncertainty; slight production volume increases expected, with new customer awards ramping up in H2 2026.
Automotive demand expected to improve modestly, while non-automotive markets lag.
Cost reduction and efficiency initiatives continue; meaningful sales progress anticipated in Q4 2026 and full year 2027.
Latest events from Chicago Rivet & Machine
- Sales and margins declined sharply in Q1 2026, raising substantial going concern risks.CVR
Q1 2026 - Annual meeting to elect directors and ratify auditor, with strong governance and risk oversight.CVR
Proxy filing - Substantial doubt remains about going concern status despite improved margins and narrowed losses.CVR
Q4 2025 - Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing - Returned to profitability in Q3 2025, but going concern risks persist amid industry challenges.CVR
Q3 2025 - Q2 2024 returned to profit on improved margins, despite flat sales and ongoing risk from a product issue.CVR
Q2 2024 - Sales fell 12.3% YoY in Q3 2024, with improved margins but a net loss of $1.45M.CVR
Q3 2024 - Significant 2024 losses, liquidity risks, and operational restructuring amid industry headwinds.CVR
Q4 2024 - Gross margin and net income improved despite lower sales, but liquidity risks persist.CVR
Q1 2025